Flu vaccine manufacturer Sanofi Pasteur is working with artificial intelligence (AI) company Berg in a study using AI to identify biomarkers that reveal how well or badly a flu shot is performing. Flu vaccines were around 48% effective during the 2016-2017 season, according to the US Centers for Disease Control. The billions firms are hoping to improve that figure with personalised vaccines developed using a combination of 'multi-omic' molecular data and AI.
Flu vaccine manufacturer Sanofi Pasteur is working with artificial intelligence (AI) company Berg in a study using AI to identify biomarkers that reveal how well or badly a flu shot is performing. Flu vaccines were around 48% effective during the 2016-2017 season, according to the US Centers for Disease Control. The two firms are hoping to improve that figure with personalised vaccines developed using a combination of 'multi-omic' molecular data and AI.